Meta Platforms, Inc. (NASDAQ:META) is one of the Trending AI Stocks on Wall Street. On November 10, Erste Group downgraded ...
A meta-analysis published this week by the Journal of Ethnological Substance Abuse reports that cannabis use is linked to a ...
Meta finds itself confronting a significant leadership crisis that threatens to undermine its multi-billion dollar artificial ...
A wave of selling pressure and negative headlines surrounding Meta may be facing its first significant challenge. In a ...
After snapping its 20-day win streak earlier this week, is Meta Platforms (META) stock overdue for a split? Citi senior analyst of Internet Equity Research Ron Josey says that a split is unlikely, ...
Meta Platforms shows strong ad growth, Family of Apps engagement, and high ROIC with long-term value potential. Learn why META stock is a buy.
Detailed price information for Meta Platforms Inc (META-Q) from The Globe and Mail including charting and trades.
Medpage Today on MSN
Meta-Analyses Argue for Broader Use of SGLT2 Inhibitors in Chronic Kidney Disease
The first meta-analysis analyzed 70,361 participants from 10 randomized trials, and found those allocated to receive an SGLT2 ...
META’s stock has seen a solid 43% rise in the last six months. This growth is primarily fueled by a mix of factors, including upbeat quarterly performance and significant AI investments that boosted ...
Management used the latest update to lift its spending plans. For 2025, Meta now expects total expenses between $116 billion and $118 billion and capital expenditures in a range of $70 billion to $72 ...
Key metrics all show the core social media business continuing to deliver strong growth. Active people across its family of ...
Detailed price information for Meta Platforms Inc (META-Q) from The Globe and Mail including charting and trades.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback